Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies
Go back to Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies| (NASDAQ: QNRX) | Delayed: 4.79 +0.22 (4.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.57 | 52 Week High | $ | |||
| Open | $4.79 | 52 Week Low | $ | |||
| Day High | $4.90 | P/E | N/A | |||
| Day Low | $4.70 | EPS | $ | |||
| Volume | 17,367 | |||||
| Skinvisible, Inc. (AMEX: SKVI) | Delayed: 0.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.18 | 52 Week High | $0.04 | |||
| Open | $0.18 | 52 Week Low | $0.00 | |||
| Day High | $0.18 | P/E | N/A | |||
| Day Low | $0.18 | EPS | $-0.01 | |||
| Volume | 12,387,558 | |||||
